A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART
Clinical trial NCT02454556 · COMPLETED
Trial details
- NCT number
- NCT02454556
- Sponsor
- Gema Biotech S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-12-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.